–
SAB Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.4
FY22:
−28.9
FY23:
−38.1
FY24:
−42.9
FY25:
−49.0
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−46.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.1
FY22:
−18.7
FY23:
−42.2
FY24:
–
FY25:
13.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.1
FY22:
−18.7
FY23:
−42.2
FY24:
−34.1
FY25:
13.3
All amounts in millions USD